Fact checked byKristen Dowd

Read more

December 30, 2022
2 min read
Save

Top 10 asthma, allergy stories of 2022

Fact checked byKristen Dowd
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers continued to investigate how to help allergy and asthma patients breathe easier, eat better, and live safer and more satisfying lives in 2022. Here are our top 10 stories about these developments this year.

Maternal diet during pregnancy may impact development of asthma, allergies in offspring

Pregnant moms who eat plenty of veggies and fewer fried, low-fiber and sugary foods may see fewer allergies and asthma in their babies, said Carina Venter, PhD, RD, during the American Academy of Allergy, Asthma & Immunology Annual Meeting. Read more.

71% of children aged 12 to 23.9 months achieved remission with peanut oral immunotherapy, while 35% of children aged 24 to 35.9 months and 19% of children aged 36 to 47.9 months.

Intranasal corticosteroids mitigate loss of smell in chronic rhinosinusitis with COVID-19

Doctors should consider intranasal corticosteroids for patients with chronic rhinosinusitis who also have COVID-19 to minimize loss of olfactory function, according to a study published in Allergy and Asthma Proceedings. Read more.

Sexual intercourse may trigger asthma exacerbations

Ariel Leung

Much like exercise-induced asthma, sexual intercourse also can trigger asthma exacerbations, Ariel Leung, MD, reported during the American College of Allergy, Asthma & Immunology Annual Meeting. Read more.

Food allergy associated with lower SARS-CoV-2 infection risk

People with food allergies showed lower risk for SARS-CoV-2 infection, whereas those with current asthma and those with obesity had a higher risk, according to a study published in The Journal of Allergy and Clinical Immunology. Read more.

Oral immunotherapy may lead to remission of peanut allergy in young children

Edwin H. Kim

Oral immunotherapy was associated with an increase in both desensitization and remission of peanut allergy among children aged younger than 4 years, Edwin H. Kim, MD, MS, and colleagues wrote in a study published in The Lancet. Read more.

Nasal spray found effective in reducing symptoms from house dust mite allergic rhinitis

The drug-free AM-301 (Bentrio, Altamira Therapeutics) forms a protective gel layer on the nasal mucosa after application and keeps viruses and allergens from coming in contact with cells, according to the nasal spray’s manufacturer. Read more.

Sublingually administered epinephrine continues to show promise

John Oppenheimer

The rapid attainment of peak blood levels following sublingual film administration is notable for a product that is being developed as an anaphylaxis rescue medication, where time to clinical effect is an important consideration, John Oppenheimer, MD, FAAAAI, told Healio. Read more.

Probiotic supplements may improve asthma control, lung function

Probiotic supplements such as Bifidobacterium infantis 35624 could improve asthma control and lung function while reducing the need to use rescue inhalers, according to a letter published in Annals of Allergy, Asthma & Immunology. Read more.

Physicians show lack of knowledge surrounding diagnosis, treatment of anaphylaxis

Less than half of physicians identified gastrointestinal and upper respiratory tract symptoms as potential signs of anaphylaxis, according to findings presented at the European Academy of Allergy and Clinical Immunology Hybrid Congress. Read more.

Hazelnut oral immunotherapy appears effective for children

Oral immunotherapy appeared effective and well-tolerated by children with hazelnut allergy, although there was a high treatment discontinuation rate, according to a retrospective study published in Annals of Allergy, Asthma & Immunology. Read more.